You are here

Sanuwave

Biotech's Fallen Angels: Identifying Irrational Market Behavior

Seeking Alpha

Mon, 04/8/13 - 12:00 pm

Arena Pharmaceuticals

SANUWAVE Reports Third Quarter 2012 Financial Results

Wed, 11/14/12 - 10:55 pm

SANUWAVE Reports Second Quarter 2012 Financial Results and Provides a Business Update

Thu, 08/9/12 - 12:55 am

SANUWAVE Receives Conditional Approval from the FDA on Clinical Trial Plan for dermaPACE

Tue, 05/8/12 - 09:06 pm

Sanuwave takes its dermaPace foot ulcer treatment back to trials

Fri, 03/16/12 - 11:34 pm

clinical trials

SANUWAVE Reports 2011 Financial Results and Provides Update on dermaPACE FDA Status

Wed, 03/14/12 - 10:08 pm

SANUWAVE Issued U.S. Patent for the Application of Acoustic Shock Waves Utilizing Its PACE Devices

Sat, 01/7/12 - 03:23 am

FDA wants another dermaPACE study from Sanuwave

Fri, 12/23/11 - 05:37 pm

SANUWAVE Updates on FDA Review of dermaPACE Premarket Approval Application

Wed, 12/21/11 - 11:33 pm

Odds Look Good For SANUWAVE's Pending FDA Decision

Sat, 10/8/11 - 12:37 am

SANUWAVE Appoints Medical Technology Veteran Ron Sparks to Board of Directors

Wed, 09/21/11 - 10:15 pm

FDA Decision Pending On Sanuwave's Disruptive Multi-Billion Dollar Market Technology

Tue, 08/23/11 - 11:05 pm

SANUWAVE Health Reports Second Quarter Financial Results and Provides Business Update

Wed, 08/10/11 - 04:24 pm

SANUWAVE Announces American Medical Association Approval of CPT Category III Codes for Extracorporeal Shock Wave Technology in Wound Healing

Tue, 07/19/11 - 11:45 am

Extracorporeal Shock Wave Technology

SANUWAVE Health Submits Final Module of PMA Application for FDA Approval of dermaPACE to Treat Diabetic Foot Ulcers

Wed, 07/6/11 - 01:22 pm

SANUWAVE Health Wins Patent Challenge

Tue, 06/14/11 - 01:23 pm

SANUWAVE Extracorporeal Shock Wave Technology Shown to Prevent and Repair Osteoarthritis Damage in Preclinical Model

Thu, 06/9/11 - 07:40 pm

Novel Wound Care Device Could Be Big

Wed, 05/4/11 - 11:23 pm

diabetic foot ulcers

Sanuwave Completes Patient Follow-up in Phase III Trial of Dermapace for the Treatment of Diabetic Foot Ulcers

Tue, 09/21/10 - 01:08 pm

diabetic foot ulcers